| Short Description : | Recombinant-Human HIV-1 gp120-protein was developed from. For use in research applications. |
| Note: | STRICTLY FOR FURTHER RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Conjugation: | Unconjugated |
| Formulation: | 0.2 µm filtered 50mM Tris pH 8.0 NaCl 60mM, 10mM Glutathione, 0.25% Sarkosyl, 50% Glycerol |
| Storage Instruction: | Can be stored in working aliquots at°C-°C C for one month, or at-20°C C for six months, with a carrier protein without detectable loss of activity. Avoid repeated freeze/thaw cycles. NA |
| Endotoxin: | Endotoxin content was assayed using a LAL gel clot method. Endotoxin level was found to be less than.1 ng/µg (1EU/µg). NA |
| Immunoreactivity: | Immunoreative with sera of infected HIV individuals NA |
| Background | Recombinant HIV-1 Glycoprotein gp120 contains a GST purification tag and migrates as an approximately 35 kDa protein under reducing conditions in SDS-PAGE. |
Information sourced from Uniprot.org